BeStock  

Edwards Lifesciences EW

US equityMarket cap rank #310Medical Devices
$85.23 −$1.09 (-1.26%)
Market open · Oct 1, 1:20 pm ET · After hours $86.32 0.00%
Open$86.00
Prev close$86.32
Day range$85.03 – $86.84
Volume910.3K
Market cap$49.13B
P/E (TTM)49.6
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$1.74B+13.6% YoY
Operating profit$519.50M+20.6% YoY
Net profit$241.40M-27.2% YoY
Diluted EPS$0.42-25.0% YoY
Free cash flow$585.00M+142.8% YoY
Operating cash flow$651.90M

Revenue, last 8 quarters

$1.4BSep '24$1.4BDec '24$1.4BMar '25$1.5BJun '25$1.6BSep '25$1.6BDec '25$1.6BMar '26$1.7BJun '26

Net profit, last 8 quarters

$3.1BSep '24$384.3MDec '24$356.4MMar '25$331.5MJun '25$290.3MSep '25$91.2MDec '25$380.7MMar '26$241.4MJun '26

Diluted EPS by quarter

5.13Sep '240.65Dec '240.61Mar '250.56Jun '250.50Sep '250.16Dec '250.66Mar '260.42Jun '26

Free cash flow by quarter

$294.5MSep '24$-181.9MDec '24$224.4MMar '25$240.9MJun '25$516.2MSep '25$353.5MDec '25$-21.1MMar '26$585.0MJun '26

Annual revenue

$4.4BFY20$5.2BFY21$4.5BFY22$5.0BFY23$5.4BFY24$6.1BFY25

Profitability & balance sheet

Gross margin77.8%
Operating margin28.1%
Net margin15.4%
Return on equity9.5%
Return on assets7.3%
Return on invested capital7.9%
Current ratio4.52
Liabilities / assets22.7%
Cash & investments$4.25B
Total debt$680.30M
Net cash (debt)$3.57B
Free cash flow / sales22.0%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $1.74B $1.65B $6.07B $1.57B $1.55B
Total Operating Revenue $1.74B $1.65B $6.07B $1.57B $1.55B
Cost of Revenue $392.40M $362.60M $1.33B $343.00M $345.20M
Gross Profit $1.35B $1.29B $4.73B $1.23B $1.21B
Operating Expense $829.10M $771.30M $3.10B $856.30M $782.80M
Selling and Admin Expenses $561.20M $522.20M $2.09B $602.90M $514.60M
Research & Development $278.90M $263.30M $1.08B $267.70M $280.70M
Other Operating Expenses -$11.00M -$14.20M -$67.20M -$14.30M -$12.50M
Operating Profit $519.50M $514.70M $1.64B $370.30M $425.10M
Net Non-Operating Interest Income (Expense) $30.00M $33.50M $148.40M $35.90M $38.60M
Non-Operating Interest Income $30.00M – $168.80M $56.30M $38.60M
Other Income (Expense) -$29.70M -$89.20M -$511.70M -$315.80M -$115.30M
Special Income (Charges) -$46.30M -$160.70M -$518.90M -$319.00M -$118.00M
-Less:Restructuring and Mergern & Acquisition $0.00 $0.00 $6.60M $10.60M -$12.40M
-Less:Other Special Charges $6.30M $37.10M $325.40M $208.60M $90.40M
-Less:Write Off $40.00M $123.60M $146.90M $99.80M $0.00
Other Non-Operating Income (Expenses) $16.60M $71.50M $3.20M -$800,000.00 $2.70M
Pretax Profit $519.80M $459.00M $1.27B $90.40M $348.40M
Tax $278.40M $78.30M $216.90M $26.20M $56.10M
Net Profit $241.40M $380.70M $1.07B $91.20M $290.30M
Profit from Continuing Operations $241.40M $380.70M $1.06B $64.20M $292.30M
Net Income from Discontinuous Operations $0.00 $0.00 $13.40M $27.00M -$2.00M
Minority Interests -$500,000.00 $0.00 -$4.10M $0.00 -$800,000.00
Net Income to Parent Company $241.90M $380.70M $1.07B $91.20M $291.10M
Net Income to Common Stockholders $241.90M $380.70M $1.07B $91.20M $291.10M
Basic EPS $0.42 $0.66 $1.84 $0.16 $0.50
Diluted EPS $0.42 $0.66 $1.83 $0.16 $0.50
Total Other Finance Costs – -$33.50M – – –
Non-Operating Interest Expense – – $20.40M – –
Gain on Sale of Security – – $4.00M – –
-Less:Impairment of Capital Assets – – $40.00M $0.00 $40.00M

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $13.87B $13.32B $13.70B $13.70B $13.27B
Total Current Assets $6.82B $6.23B $6.74B $6.74B $6.36B
Cash and Cash Equivalents & Short-Term Investments $4.25B $3.67B $4.23B $4.23B $3.84B
-Cash and Cash Equivalents $2.91B $2.45B $2.94B $2.94B $2.69B
-Short Term Investments $1.35B $1.23B $1.29B $1.29B $1.16B
Receivables $955.70M $973.00M $912.10M $912.10M $892.80M
-Accounts Receivable $770.40M $775.70M $659.60M $659.60M $693.30M
-Other Receivables $185.30M $197.30M $252.50M $252.50M $199.50M
Prepaid Assets $119.00M $135.70M $135.00M $135.00M $125.20M
Inventory $1.13B $1.12B $1.13B $1.13B $1.14B
Other Current Assets $360.30M $329.50M $339.30M $339.30M $323.40M
Total Non-Current Assets $7.05B $7.09B $6.96B $6.96B $6.91B
Net PPE $1.94B $1.92B $1.91B $1.91B $1.84B
-Gross PPE $1.94B $1.92B $2.76B $2.76B $1.84B
Investments and Advances $244.10M $285.60M $278.60M $278.60M $274.70M
Financial Assets $14.60M $14.20M $5.80M $5.80M $5.10M
Non Current Accounts Receivables $412.10M $400.10M $314.80M $314.80M $303.90M
Non-Current Note Receivables $68.80M $137.20M $173.70M $173.70M $227.30M
Non-Current Prepaid Assets $89.20M $91.30M $93.30M $93.30M $95.70M
Goodwill and Other Intangible Assets $3.33B $3.05B $2.90B $2.90B $2.90B
-Goodwill $1.95B $1.82B $1.77B $1.77B $1.77B
-Other Intangible Assets $1.38B $1.23B $1.13B $1.13B $1.13B
Non-Current Deferred Assets $911.80M $1.10B $1.14B $1.14B $1.10B
Other Non-Current Assets $31.70M $96.10M $142.60M $142.60M $167.60M
Total Liabilities $3.14B $2.99B $3.36B $3.36B $3.07B
Total Current Liabilities $1.51B $1.41B $1.81B $1.81B $1.59B
Payables $481.00M $475.40M $504.90M $504.90M $388.00M
-Accounts Payable $210.50M $181.10M $227.50M $227.50M $165.00M
-Total Tax Payable $270.50M $294.30M $277.40M $277.40M $223.00M
Current Accrued Expenses $595.80M $606.00M $714.30M $714.30M $601.00M
Short-Term Debt and Capital Lease Obligation $24.10M $24.30M $24.50M $24.50M $26.80M
-Current Capital Lease Obligation $24.10M $24.30M $24.50M $24.50M $26.80M
Current Provisions $7.50M $7.50M $50.00M $50.00M $64.80M
Current Deferred Liabilities $20.30M $22.80M $27.20M $27.20M $33.20M
Other Current Liabilities $6.30M $7.60M $25.30M $25.30M $36.80M
Total Non-Current Liabilities $1.63B $1.58B $1.55B $1.55B $1.48B
Long Term Debt and Capital Lease Obligation $680.30M $678.60M $680.90M $680.90M $673.50M
-Long Term Debt $598.70M $598.50M $598.30M $598.30M $598.20M
-Long Term Capital Lease Obligation $81.60M $80.10M $82.60M $82.60M $75.30M
Other Non-Current Liabilities $954.00M $906.10M $865.00M $865.00M $805.50M
Total Equity $10.72B $10.33B $10.34B $10.34B $10.21B
Stockholders' Equity $10.62B $10.33B $10.34B $10.34B $10.21B
Capital Stock $661.70M $660.00M $658.70M $658.70M $658.20M
-Common Stock $661.70M $660.00M $658.70M $658.70M $658.20M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.98B $2.78B $2.77B $2.77B $2.70B
Retained Earnings $14.86B $14.62B $14.24B $14.24B $14.15B
Less: Treasury Stock $7.67B $7.51B $7.09B $7.09B $7.05B
Gains/Losses Not Affecting Retained Earnings -$214.60M -$221.30M -$238.30M -$238.30M -$250.40M
Minority Interests $106.90M – $0.00 $0.00 $0.00
-Accumulated Depreciation – – -$849.80M -$849.80M –
-Available for Sale Securities – – $243.90M $243.90M $240.70M
-Long Term Equity Investment – – $34.70M $34.70M $34.00M
Non-Current Accrued Expenses – – $0.00 $0.00 –
-Held to Maturity Securities – – – – $0.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $651.90M $43.80M $1.60B $450.90M $573.70M
Net cash flow from continuing operations $651.90M $43.80M $1.60B $450.90M $573.70M
Net Income from Continuing Operations $241.40M $380.70M $1.07B $91.20M $290.30M
Depreciation & Depletion & Amortization $42.70M $40.90M $156.60M $42.70M $39.20M
Deferred Tax $181.30M $9.40M -$117.60M -$54.40M -$18.00M
Other Non-Cash Items -$24.10M -$58.20M -$12.80M -$21.90M -$11.70M
Change in Working Capital $131.90M -$501.50M $154.60M $254.30M $192.70M
-Change in Receivables -$10.20M -$117.90M -$23.00M $32.40M $13.20M
-Change in Inventory -$23.50M -$1.60M $50.70M $11.00M -$1.80M
-Change in Prepaid Assets $29.50M -$8.70M -$15.40M $2.10M -$14.20M
-Change in Payables and Accrued Expense $123.70M -$397.10M $318.60M $153.90M $213.60M
-Change In Other Working Capital $12.40M $23.80M -$176.30M $54.90M -$18.10M
Net cash flow from investing -$193.20M -$92.80M -$712.90M -$198.30M -$427.80M
Net Cash Flow from Continuing Investing Activities -$193.20M -$92.80M -$712.90M -$198.30M -$427.80M
Capital Expenditure -$66.90M -$64.90M -$260.20M -$97.40M -$57.50M
Net Business Purchase and Sale -$5.70M -$41.40M -$101.10M -$15.00M -$37.80M
Net Investment Purchase and Sale -$115.60M $69.00M -$282.10M -$117.70M -$341.50M
Net Other Investing Changes -$5.00M -$55.50M -$69.50M $31.80M $9.00M
Financing Cash Flow -$300,000.00 -$451.20M -$956.80M -$11.40M -$740.10M
Net Cash Flow from Continuing Financing Activities -$300,000.00 -$451.20M -$956.80M -$11.40M -$740.10M
Net Common Stock Issuance -$153.30M -$421.80M -$893.40M -$40.60M -$588.70M
Proceeds from Stock Option Exercised $53.80M $68.90M $174.10M $32.30M $34.70M
Net Other Financing Charges $99.20M -$98.30M -$237.50M -$3.10M -$186.10M
Ending Cash Balance $2.91B $2.45B $2.94B $2.94B $2.69B
Net Change in Cash $458.40M -$500.20M -$74.50M $241.20M -$594.20M
Beginning Cash Balance $2.45B $2.94B $3.06B $2.69B $3.29B
Effect of Exchange Rate Changes $3.80M $8.20M -$44.80M $3.50M -$1.00M
Free Cash Flow $585.00M -$21.10M $1.34B $353.50M $516.20M
Gain/Loss from Continuing Operations – $3.50M – – –
Net Intangibles Purchase and Sale – – $0.00 $0.00 –

Discussion

No comments yet — be the first to weigh in on EW.

Leave a comment

Scroll to Top